Wohua reports strong H1 earnings
Wohua Pharmaceuticals has reported a net profit of RMB 44.68 million in H1 2025, up 303.16% YoY, on revenue of RMB 425 million. Basic EPS was RMB 0.08, and the company proposed a cash dividend of RMB 1.2 per ten shares.